{"filing": {"accession": "0001493152-26-045371", "cik": "0001541157", "ticker": "AKTX", "company_name": "Akari Therapeutics Plc", "form_type": "DEF 14A", "filing_type": "DEF 14A", "filing_date": "2026-10-01", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1541157/000149315226045371/0001493152-26-045371-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1541157/000149315226045371/0001493152-26-045371-index.htm", "period_of_report": "2026-10-01"}, "html_url": "/api/filings/000149315226045371/stream", "exhibits": [], "sections": [], "tables": [{"table_index": 0, "table_type": "text", "caption": null, "header_text": "\u2610Preliminary\n Proxy Statement"}, {"table_index": 1, "table_type": "exhibit_index", "caption": null, "header_text": "\u2612No\n fee required"}, {"table_index": 4, "table_type": "text", "caption": null, "header_text": "Yours\n sincerely,"}, {"table_index": 8, "table_type": "text", "caption": null, "header_text": "By\n Order of the Board of Directors of"}, {"table_index": 10, "table_type": "text", "caption": null, "header_text": "Page"}, {"table_index": 15, "table_type": "text", "caption": null, "header_text": "ResolutionDescription\n of ResolutionBoard\u2019sRecommendation"}, {"table_index": 18, "table_type": "text", "caption": null, "header_text": "a)Mailing\n a revised form of proxy dated later than the prior form of proxy; or"}, {"table_index": 26, "table_type": "text", "caption": null, "header_text": "Plan CategoryNumber ofSecurities to beIssued UponExercise ofOutstandingOptions, Warrantsand RightsWeighted-AverageExercise Price ofOutstandingOptions,Warrants andRights(2)Number ofSecuritiesRemainingA"}, {"table_index": 27, "table_type": "text", "caption": null, "header_text": "(1)Consists\n of our 2014 Plan and 2023 Plan and the awards granted under the incentive plan of Peak Bio Inc. assumed at closing of the acquisition.\n As of December 31, 2025, new awards are only availa"}, {"table_index": 28, "table_type": "text", "caption": null, "header_text": "\u25cfeach\n person or entity, including any \u201cgroup\u201d as that term is used in Section 13(d)(3) of the Exchange Act, who is known by\n us to own beneficially more than 5% of the issued and outstanding shares o"}, {"table_index": 30, "table_type": "text", "caption": null, "header_text": "Number ofPercentage of"}, {"table_index": 36, "table_type": "text", "caption": null, "header_text": "No.ResolutionForAgainstAbstain(see\n note 2)"}, {"table_index": 38, "table_type": "text", "caption": null, "header_text": "1.Please\n indicate with an \u201cX\u201d in the appropriate box how you wish the proxy to vote. In the absence of any indication, the proxy\n will exercise his/her discretion as to whether and how he/she votes; "}], "exhibits_pending": false, "cdn_html": true, "response_time_ms": 40}